BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15451897)

  • 1. Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes.
    Sommerfield AJ; Deary IJ; Frier BM
    Diabetes Care; 2004 Oct; 27(10):2335-40. PubMed ID: 15451897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between instrumental activities of daily living and blood glucose control in elderly subjects with type 2 diabetes.
    Bossoni S; Mazziotti G; Gazzaruso C; Martinelli D; Orini S; Solerte SB; Romanelli G; Giustina A
    Age Ageing; 2008 Mar; 37(2):222-5. PubMed ID: 18033779
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial.
    Cukierman-Yaffe T; Bosch J; Diaz R; Dyal L; Hancu N; Hildebrandt P; Lanas F; Lewis BS; Marre M; Yale JF; Yusuf S; Gerstein HC;
    Lancet Diabetes Endocrinol; 2014 Jul; 2(7):562-72. PubMed ID: 24898834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study.
    Abbatecola AM; Bo M; Barbagallo M; Incalzi RA; Pilotto A; Bellelli G; Maggi S; Paolisso G;
    J Am Med Dir Assoc; 2015 Apr; 16(4):349.e7-12. PubMed ID: 25669671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term, delayed, and working memory are impaired during hypoglycemia in individuals with type 1 diabetes.
    Sommerfield AJ; Deary IJ; McAulay V; Frier BM
    Diabetes Care; 2003 Feb; 26(2):390-6. PubMed ID: 12547868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study.
    Verdelho A; Madureira S; Ferro JM; Basile AM; Chabriat H; Erkinjuntti T; Fazekas F; Hennerici M; O'Brien J; Pantoni L; Salvadori E; Scheltens P; Visser MC; Wahlund LO; Waldemar G; Wallin A; Inzitari D;
    J Neurol Neurosurg Psychiatry; 2007 Dec; 78(12):1325-30. PubMed ID: 17470472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic nephropathy and retinopathy.
    Jawa A; Kcomt J; Fonseca VA
    Med Clin North Am; 2004 Jul; 88(4):1001-36, xi. PubMed ID: 15308388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemia and cognitive function in older adults using glucose-lowering drugs.
    Shorr RI; de Rekeneire N; Resnick HE; Yaffe K; Somes GW; Kanaya AM; Simonsick EM; Newman AB; Harris TB
    J Nutr Health Aging; 2006; 10(4):297-301. PubMed ID: 16886100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of chronic and acute glycemic control on mortality in acute myocardial infarction with diabetes mellitus.
    Cao JJ; Hudson M; Jankowski M; Whitehouse F; Weaver WD
    Am J Cardiol; 2005 Jul; 96(2):183-6. PubMed ID: 16018838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of acute hypoglycemia on motivation and cognitive interference in people with type 1 diabetes.
    McAulay V; Deary IJ; Sommerfield AJ; Matthews G; Frier BM
    J Clin Psychopharmacol; 2006 Apr; 26(2):143-51. PubMed ID: 16633142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term effects of improved glycemic control on cognitive function in patients with type 2 diabetes.
    Hewer W; Mussell M; Rist F; Kulzer B; Bergis K
    Gerontology; 2003; 49(2):86-92. PubMed ID: 12574669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of type II diabetes mellitus in population of Krakow].
    Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
    Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression, anxiety and cognitive function in patients with type 2 diabetes: an 8-year prospective observational study.
    Trento M; Charrier L; Salassa M; Merlo S; Passera P; Cavallo F; Porta M
    Acta Diabetol; 2015 Dec; 52(6):1157-66. PubMed ID: 26374233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes.
    Fanelli CG; Paramore DS; Hershey T; Terkamp C; Ovalle F; Craft S; Cryer PE
    Diabetes; 1998 Dec; 47(12):1920-7. PubMed ID: 9836525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attentional functioning is impaired during acute hypoglycaemia in people with Type 1 diabetes.
    McAulay V; Deary IJ; Sommerfield AJ; Frier BM
    Diabet Med; 2006 Jan; 23(1):26-31. PubMed ID: 16409562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cognitive decline in elderly individuals with type 2 diabetes mellitus].
    Sakurai T
    Nihon Rinsho; 2013 Nov; 71(11):1960-4. PubMed ID: 24397166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of glycemic control on protective responses against hypoglycemia in type 2 diabetes.
    Korzon-Burakowska A; Hopkins D; Matyka K; Lomas J; Pernet A; Macdonald I; Amiel S
    Diabetes Care; 1998 Feb; 21(2):283-90. PubMed ID: 9539997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relationship Between the Score on a Simple Measure of Cognitive Function and Incident CVD in People With Diabetes: A Post Hoc Epidemiological Analysis From the ACCORD-MIND Study.
    Cukierman-Yaffe T; Gerstein HC; Miller ME; Launer LJ; Williamson JD; Horowitz KR; Ismail-Beigi F; Lazar RM
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3218-3225. PubMed ID: 28575229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consistent Effects of Hypoglycemia on Cognitive Function in People With or Without Diabetes.
    Verhulst CEM; Fabricius TW; Nefs G; Kessels RPC; Pouwer F; Teerenstra S; Tack CJ; Broadley MM; Kristensen PL; McCrimmon RJ; Heller S; Evans ML; Pedersen-Bjergaard U; de Galan BE
    Diabetes Care; 2022 Sep; 45(9):2103-2110. PubMed ID: 35876660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.
    Carroll MF; Izard A; Riboni K; Burge MR; Schade DS
    Diabetes Care; 2002 Dec; 25(12):2147-52. PubMed ID: 12453952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.